Dia: 21 de janeiro de 2013

Rejected hearts now viable for transplantation after stress echo

“Pharmacological stress echo is already an established technique that is used to assess and risk stratify patients with known or suspected coronary artery disease. We have shown that it can also be used to identify hearts suitable for transplantation that would previously have been unused. This requires cardiologists with experience of stress echo and ideally a second opinion from a cardiologist in a core lab (using tele-echocardiography), who can give the green light for donation.”

Uma ideia muito boa para aumentar o número de doadores de coração e diminuir a fila de transplantes! Eleva-se a idade permitida com a segurança do ecostresse normal.

Impact of tricuspid regurgitation on survival in patients with chronic heart failure: unexpected findings of a long-term observational study……………………………………………Eur Heart J (2013) doi: 10.1093/eurheartj/ehs465

In patients with mildly or moderately impaired LVF, TR was significantly related with the outcome (HR: 1.368, CI: 1.070–1.748, P = 0.0125), whereas in patients with severely depressed LVF it was not (P = 0.1401). /////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////Conclusion The prognostic impact of TR depends on the severity of CHF. While TR was significantly related with excess mortality in mild to moderate CHF, it provided no additive value in advanced disease when compared with established risk factors.

Quando a insuficiência tricúspide é significativa, o prognóstico muda. Mas apenas nos estágios iniciais da insuficiência cardíaca. Outro estudo publicado no blog era mais amplo no impacto da regurgitação tricúspide. A conclusão é que devemos nos esforçar para fazer uma classificação adequada do grau de insuficiência ao Eco e deixar o clínico decidir.